Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Gains from Investment Securities (2016 - 2025)

Arrowhead Pharmaceuticals' Gains from Investment Securities history spans 16 years, with the latest figure at $19000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 72.73% year-over-year to $19000.0; the TTM value through Dec 2025 reached $8000.0, up 100.21%, while the annual FY2024 figure was -$3.7 million, N/A changed from the prior year.
  • Gains from Investment Securities reached $19000.0 in Q4 2025 per ARWR's latest filing, up from -$11000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $10.2 million in Q2 2021 to a low of -$63.0 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is -$4.3 million, with a median of $49500.0 recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: soared 125.19% in 2021, then tumbled 86.25% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $3.2 million in 2021, then crashed by 237.73% to -$4.4 million in 2022, then soared by 101.81% to $80000.0 in 2023, then crashed by 86.25% to $11000.0 in 2024, then surged by 72.73% to $19000.0 in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Gains from Investment Securities are $19000.0 (Q4 2025), -$11000.0 (Q1 2025), and $11000.0 (Q4 2024).